IMMPHENTIV (phenylephrine hydrochloride)
IMMPHENTIV is indicated for the treatment of Cough; Nasal Congestion; Pain; Sore Throat; Headache; Runny Nose; Sneezing; Fever.
Details
- Status
- Prescription
- First Approved
- 2012-12-20
- Patent Cliff
- 2036
- Routes
- INTRAVENOUS
- Dosage Forms
- SOLUTION
IMMPHENTIV Approval History
What IMMPHENTIV Treats
8 indicationsIMMPHENTIV is approved for 8 conditions since its original approval in 2012. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Cough
- Nasal Congestion
- Pain
- Sore Throat
- Headache
- Runny Nose
- Sneezing
- Fever
IMMPHENTIV Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
MoA expansion candidates
Same target(s), different indications — where else is this mechanism being explored?
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to IMMPHENTIV
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
2 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT05997732 STARS | Pro00126600 | Ph 4 | recruiting | Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences |
| NCT03098680 PRIME | PRIME (A094136) | Ph 1 | terminated | A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
IMMPHENTIV FDA Label Details
Indications & Usage
FDA Label (PDF)IMMPHENTIV is indicated for the treatment of Cough; Nasal Congestion; Pain; Sore Throat; Headache; Runny Nose; Sneezing; Fever.
Pro Intelligence Preview
Deep insights for IMMPHENTIV
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2036
- • 12 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • 20 similar drugs
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.